Title (en)

LEISHMANIA CYSTEINE PROTEINASES

Title (de)

LEISHMANIA CYSTEIN-PROTEINASE

Title (fr)

CYSTEINE-PROTEINASES DE LEISHMANIES

Publication

EP 1067961 A2 20010117 (EN)

Application

EP 99915864 A 19990406

Priority

• GB 9900889 W 19990406
• GB 9807293 A 19980403

Abstract (en)

[origin: WO9951264A2] The present invention relates to a Leishmania vaccine, more particularly a Leishmania vaccine comprising active or inactive cysteine proteinase(s), particularly in recombinant form, for use in immunising mammals, such as dogs and/or humans.

IPC 1-7

A61K 39/008; C07K 14/44; C12N 15/30

IPC 8 full level

A61K 39/008 (2006.01); A61P 33/02 (2006.01); C07K 14/44 (2006.01); C12N 9/64 (2006.01); C12N 15/30 (2006.01); A61K 39/00 (2006.01)

CPC (source: EP)

A61K 39/008 (2013.01); A61P 33/02 (2018.01); C07K 14/44 (2013.01); C12N 9/6472 (2013.01); A61K 39/00 (2013.01); Y02A 50/30 (2018.01)

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

DOCDB simple family (publication)

WO 9951264 A2 19991014; WO 9951264 A3 19991209; AP 2000001945 A0 20001231; BR 9909388 A 20001205; EP 1067961 A2 20010117; GB 9807293 D0 19980603; IL 138639 A0 20011031

DOCDB simple family (application)

GB 9900889 W 19990406; AP 2000001945 A 19990406; BR 9909388 A 19990406; EP 99915864 A 19990406; GB 9807293 A 19980403; IL 13863999 A 19990406